| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2005.04.2127 |
| P698 | PubMed publication ID | 16575002 |
| P50 | author | James Rutka | Q17156655 |
| Uri Tabori | Q43826656 | ||
| David Malkin | Q47460858 | ||
| Eric Bouffet | Q64584887 | ||
| Ute Bartels | Q64584924 | ||
| Cynthia Hawkins | Q64584929 | ||
| P2093 | author name string | Maria Zielenska | |
| Jing Ma | |||
| Michael Carter | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ependymoma | Q1346753 |
| pediatric ependymoma | Q7159224 | ||
| P304 | page(s) | 1522-1528 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma | |
| P478 | volume | 24 |
| Q36729416 | An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer |
| Q35904519 | An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes. |
| Q27011298 | Antibody, T-cell and Dendritic Cell Immunotherapy for Malignant Brain Tumors |
| Q38860452 | CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility |
| Q47719269 | Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups? |
| Q90221066 | Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine |
| Q33970971 | Childhood brain tumors: epidemiology, current management and future directions |
| Q36502912 | Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma |
| Q38081982 | Current and Evolving Knowledge of Prognostic Factors for Pediatric Ependymomas |
| Q36400631 | Diagnostic Value of Methylated Human Telomerase Reverse Transcriptase in Human Cancers: A Meta-Analysis |
| Q36764016 | Emerging monoclonal antibody therapies for malignant gliomas |
| Q38101501 | Ependymoma in children: molecular considerations and therapeutic insights. |
| Q48548464 | Ependymoma: lessons from the past, prospects for the future |
| Q37678294 | Ependymomas: development of immunotherapeutic strategies. |
| Q38736587 | Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS. |
| Q41817349 | Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors |
| Q38078472 | Genetic expression profiles of adult and pediatric ependymomas: Molecular pathways, prognostic indicators, and therapeutic targets |
| Q38460865 | Glioblastoma: pathology, molecular mechanisms and markers |
| Q34287519 | High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells |
| Q53325736 | High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis |
| Q37617838 | Histology and molecular pathology of pediatric brain tumors |
| Q37419161 | Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis |
| Q37608106 | Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper |
| Q35825515 | Infratentorial ependymomas--a study of the centre in Katowice |
| Q37414361 | Intracranial ependymoma: factors affecting outcome. |
| Q37502749 | Management strategies for recurrent ependymoma in the paediatric population |
| Q50859079 | Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. |
| Q38359284 | Molecular biology of pediatric brain tumors and impact on novel therapies |
| Q30438459 | Molecular genetics of ependymoma |
| Q36817109 | Molecularly targeted therapies for malignant gliomas: advances and challenges |
| Q37909392 | Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges |
| Q38233102 | Multidisciplinary management of pediatric intracranial ependymoma |
| Q24646111 | Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma |
| Q24658324 | New chemotherapy strategies and biological agents in the treatment of childhood ependymoma |
| Q55467886 | Paediatric ependymomas: should we avoid radiotherapy? |
| Q39719582 | Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy |
| Q21136141 | Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis |
| Q36344765 | Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis |
| Q34665512 | Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas |
| Q37440787 | Salvage chemotherapy for metastatic and recurrent ependymoma of childhood |
| Q59793008 | Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors |
| Q37030812 | Spectrum of pediatric gliomas: implications for the development of future therapies |
| Q37849262 | Supratentorial ependymoma in children: To observe or to treat following gross total resection? |
| Q37533648 | Targeted therapy for malignant glioma patients: lessons learned and the road ahead |
| Q38858546 | Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain |
| Q37532245 | Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression |
| Q30613404 | Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells |
| Q39263985 | Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells |
| Q36832376 | Telomere biology of pediatric cancer |
| Q24652958 | Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma |
| Q37904503 | Treatment of high-grade glioma in children and adolescents |
| Q36953476 | Treatment of pediatric brain tumors |
| Q38620079 | Vaccination strategies for neuro-oncology |
| Q51612185 | hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas |
| Q38835327 | hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation |
Search more.